Project Grant R00GM144688

Award Date 7/1/24
Completion Date 6/30/27
Dollars Obligated $747K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This $489,500 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support a collaborative research initiative at Boston Children's Hospital to elucidate how human microglia-like cells leverage mRNA translational control mechanisms to respond to environmental cues. The research aims to define the translational landscape...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $1,002,148 to The Regents of the University of California (University of California, Berkeley) to study the molecular, structural, and biochemical mechanisms regulating autophagy complexes and their role in neuronal quality control. The key objectives are to use cryo-electron microscopy,...
This Project Grant award of $380,546 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research on post-transcriptional regulation of stem and progenitor cell function, with a focus on spermatogonial stem and progenitor cells in the mouse model. The key objectives of the research are to: 1) Investigate how the RNA-binding protein and translational regulator DAZL enhances retinoic acid-mediated...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,199,340 to the University of Wisconsin - Madison to investigate the role of the RNA-binding protein FMRP in regulating mitochondrial function and energy metabolism during human neuron development. The key objectives are to: Investigate the impact of FMRP and RACK1 deficiency...
This Project Grant award of $404,972 from the National Cancer Institute's (NCI) Cancer Biology Research program (CFDA 93.396) supports research by the University of Texas Health Science Center at San Antonio (UTHSCSA) to investigate ribosome biogenesis and specialized translation in glioblastoma, the most aggressive form of brain cancer. The key objectives are to: 1) Identify differences in small nucleolar RNA (snoRNA) expression and rRNA modifications between glioma stem cells, astrocytes,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $316,968.00 to Emory University to study the regulation, inhibition, and quality control mechanisms of ribosomes. The 5-year project, running from June 1, 2025 to May 31, 2030, will use biochemistry and structural biology approaches to investigate three key themes: 1) translation fidelity events like miscoding and frameshift errors,...
This Project Grant award of $270,434, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by Princeton University to investigate the spatiotemporal regulation of mRNA and its role in neuronal remodeling during morphogenesis. The project will leverage Drosophila models to characterize the localization and motility of the chickadee (chic)...
This $428,973 Project Grant was awarded on September 20, 2024 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports research to investigate the functional divergence of two critical ribosomal proteins, RPL27 and RPS19, in the model organism Schizosaccharomyces pombe. The study aims to clarify whether differences in cellular phenotypes resulting from the absence of these ribosomal protein...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $658,165.00 to Triad National Security, LLC to conduct advanced research on the effects of ions on mRNA, ribosomes, and antibiotic-RNA interactions. The research aims to deepen the understanding of ribosome mechanism and mRNA regulation at the atomistic level, with a focus on the bacterial ribosome. Key areas of...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $442,750 to Case Western Reserve University to develop a novel single-cell tRNA sequencing method. The goal is to profile tRNA diversity and processing patterns in stem cell-derived neurons and cerebral organoids, with a focus on understanding tRNA biogenesis...

REGULATION OF RIBOSOME COLLISIONS DURING HEALTH, DEVELOPMENT AND DISEASE - PROJECT SUMMARY/ABSTRACT OBSTACLES ON MRNAS CAUSE EUKARYOTIC RIBOSOMES TO STALL. SEVERELY STALLED RIBOSOMES COLLIDE WITH THE UPSTREAM, TRANSLATING RIBOSOMES AND FORM A COMPLEX OF TWO RIBOSOMES, REFERRED TO AS "DISOME", WHICH IS DETECTED AND REMOVED BY THE RIBOSOME QUALITY CONTROL (RQC) PATHWAY. BY ESTABLISHING DISOME-SEQ TECHNIQUE, WHICH REVEALS GENOME-WIDE DISTRIBUTION OF RIBOSOME COLLISIONS ACROSS THE TRANSCRIPTOME, WE SHOWED THAT RQC-TARGETED DISOMES FREQUENTLY FORM ON YEAST MRNAS. WE ALSO FOUND THAT COLLISIONS IN YEAST TRIGGER THE INTEGRATED STRESS RESPONSE (ISR), WHICH REDUCES TRANSLATION WHILE INDUCING THE EXPRESSION OF SURVIVAL GENES. SIMILARLY, DISOMES ACTIVATE ISR IN HUMANS TO PROMOTE SURVIVAL, BUT ITS HYPERACTIVATION LEADS TO CELL DEATH. THIS INDICATES THAT CELLULAR HEALTH IS DETERMINED BY DISOME HOMEOSTASIS, WHICH COLLECTIVELY REFERS TO THE DISOME DISTRIBUTION ACROSS TRANSCRIPTS, THE OVERALL DISOME ABUNDANCE AND THE DOWNSTREAM RESPONSE EVOKED BY RQC/ISR. THE MECHANISMS BY WHICH RQC AND ISR DETECT DISOMES AND AFFECT COLLISION DYNAMICS, HOWEVER, ARE POORLY UNDERSTOOD. THE MUTATIONS OF RQC AND ISR COMPONENTS AS WELL AS DYSREGULATED RIBOSOME STALLING HAVE BEEN LINKED TO NEURODEVELOPMENTAL AND NEURODEGENERATIVE DISEASES. HOWEVER, THE CONTRIBUTION OF DISOME HOMEOSTASIS TO NEURONAL DIFFERENTIATION AND FUNCTION IS UNCLEAR. THE OBJECTIVE OF THIS PROPOSAL IS TO DETERMINE THE MECHANISMS OF DISOME HOMEOSTASIS, TO EXAMINE THE ROLE OF DISOME REGULATION IN NEURONS AND TO UNDERSTAND HOW ITS DYSREGULATION LEADS TO DISEASES. I HYPOTHESIZE THAT REGULATION OF DISOME HOMEOSTASIS IS IMPORTANT FOR NEURODEVELOPMENT AND NEURONAL HEALTH, AND ITS DYSREGULATION CAUSES NEURONAL PATHOLOGIES. IN AIM 1, I WILL DETERMINE THE MECHANISM OF DISOME RECOGNITION BY RQC AND ISR IN HEALTHY AND STRESSED CELLS BY USING SELECTIVE DISOME-SEQ AND SINGLE-MOLECULE FLUORESCENCE MICROSCOPY. IN AIM 2, I WILL DETERMINE THE DISTRIBUTION AND ABUNDANCE OF DISOMES, AND THE ROLE OF RQC/ISR FACTORS DURING THE DIFFERENTIATION OF INDUCED PLURIPOTENT STEM CELLS (IPSCS) INTO MATURE NEURONS BY USING FLUORESCENCE REPORTERS, DISOME-SEQ AND NEURONAL ASSAYS. IN AIM 3, I WILL DELINEATE THE LINK BETWEEN DYSREGULATION OF DISOME HOMEOSTASIS AND NEURONAL DISEASES THAT WERE PROPOSED TO AFFECT RIBOSOME STALLING BY USING DISOME-SEQ, RNA-SEQ, RQC/ISR REPORTERS AND PHENOTYPIC EXPERIMENTS IN THE CELLS WITH DISEASE MUTATIONS. I WILL FURTHER TEST THE TRANSLATION INHIBITORS AS POTENTIAL THERAPEUTICS TO AMELIORATE THE DISEASE PHENOTYPES. OVERALL, PROPOSED WORK WILL ILLUMINATE CRUCIAL INSIGHTS INTO THE REGULATION OF RIBOSOME COLLISIONS AND THEIR ROLE IN NEURONAL HOMEOSTASIS.

Posted 5/13/24